<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Arch Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">Arch Med Sci</journal-id><journal-id journal-id-type="publisher-id">AMS</journal-id><journal-title-group><journal-title>Archives of Medical Science : AMS</journal-title></journal-title-group><issn pub-type="ppub">1734-1922</issn><issn pub-type="epub">1896-9151</issn><publisher><publisher-name>Termedia Publishing House</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25395949</article-id><article-id pub-id-type="pmc">4223141</article-id><article-id pub-id-type="publisher-id">23761</article-id><article-id pub-id-type="doi">10.5114/aoms.2014.46216</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Research</subject></subj-group></article-categories><title-group><article-title>Compliance with severe sepsis bundles and its effect on patient outcomes of severe community-acquired pneumonia in a limited resources country</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Guo</surname><given-names>Qi</given-names></name><xref ref-type="aff" rid="AF0001">1</xref><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Hai-Yan</given-names></name><xref ref-type="aff" rid="AF0003">3</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Yi-Min</given-names></name><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Nong</surname><given-names>Ling-Bo</given-names></name><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Yuan-Da</given-names></name><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>He</surname><given-names>Guo-Qing</given-names></name><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Xiao-Qing</given-names></name><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Jiang</surname><given-names>Mei</given-names></name><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Xiao</surname><given-names>Zheng-Iun</given-names></name><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Zhong</surname><given-names>Nan-Shan</given-names></name><xref ref-type="aff" rid="AF0002">2</xref></contrib></contrib-group><aff id="AF0001"><label>1</label>Department of Respiratory Medicine, Affiliated Futian Hospital, Guangdong Medical College, Shenzhen, Guangdong, China</aff><aff id="AF0002"><label>2</label>Guangzhou Institute of Respiratory Diseases (State Key Laboratory of Respiratory Diseases), First Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China</aff><aff id="AF0003"><label>3</label>Department of Primary Care, Affiliated Futian Hospital, Guangdong Medical College, Shenzhen, Guangdong, China</aff><author-notes><corresp id="cor1"><bold>Corresponding author:</bold> Qi Guo MD, PhD, Guangdong Medical College, 518033 Shenzhen, China. Phone: +86 13923714808. E-mail: <email xlink:href="qiguo007@sina.com">qiguo007@sina.com</email></corresp></author-notes><pub-date pub-type="epub"><day>23</day><month>10</month><year>2014</year></pub-date><pub-date pub-type="ppub"><day>27</day><month>10</month><year>2014</year></pub-date><volume>10</volume><issue>5</issue><fpage>970</fpage><lpage>978</lpage><history><date date-type="received"><day>27</day><month>6</month><year>2012</year></date><date date-type="rev-recd"><day>29</day><month>7</month><year>2012</year></date><date date-type="accepted"><day>24</day><month>10</month><year>2012</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014 Termedia &#x00026; Banach</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Introduction</title><p>Validation of compliance with severe sepsis bundles is still needed. The purpose of this study was to determine compliance and its outcomes in severe community-acquired pneumonia (CAP) patients in a limited resources country.</p></sec><sec id="st2"><title>Material and methods</title><p>A prospective cohort study of 212 severe CAP patients was carried out. The implementation programme was organized into two continuous phases. The primary outcomes were compliance and hospital mortality.</p></sec><sec id="st3"><title>Results</title><p>Compliance with administration of antibiotics and vasopressors as well as plateau pressure on average &#x0003c; 30 cm H<sub>2</sub>O was high in both groups. In the bundles group, patients received more serum lactate monitoring (62.3% vs. 11.3%), more blood cultures (47.1% vs. 24.5%), more fluid resuscitation (63.2% vs. 26.4%) and volumes infused (1319.8 &#x000b1;1107.4 ml vs. 461.9 &#x000b1;799.3 ml), more inotropic dobutamine and/or packed red blood cells (21.7% vs. 10.0%), more low-dose steroids (56.5% vs. 15.0%), and more glucose control (51.9% vs. 6.6%) compared with such patients in the control group. The rates of total compliance with 6-hour, 24-hour, and 6/24-hour bundles in the prospective period were 47.1%, 51.9%, and 42.5%, respectively. Hospital mortality was reduced from 44.3% to 29.2% (<italic>p</italic> = 0.023) in the bundles group, and the compliant subgroup had a more than twofold decrease in mortality (17.8% vs. 37.7%, <italic>p</italic> = 0.003). Serum lactate measured, blood cultures, and fluid resuscitation showed independent relationships with decreased mortality.</p></sec><sec id="st4"><title>Conclusions</title><p>Total compliance was relatively low, but the implementation of severe sepsis bundles could clearly reduce mortality from severe CAP.</p></sec></abstract><kwd-group><kwd>severe sepsis bundles</kwd><kwd>severe community-acquired pneumonia</kwd><kwd>severe sepsis</kwd><kwd>septic shock</kwd><kwd>compliance</kwd><kwd>mortality</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="S0001"><title>Introduction</title><p>The mortality rate due to pneumonia has shown little improvement over time despite advances in antimicrobial therapy and improved intensive care medicine [<xref rid="CIT0001" ref-type="bibr">1</xref>&#x02013;<xref rid="CIT0003" ref-type="bibr">3</xref>]. It was as high as 58% when patients with severe community-acquired pneumonia (CAP) were admitted to the intensive care unit (ICU) [<xref rid="CIT0004" ref-type="bibr">4</xref>].</p><p>The Surviving Sepsis Campaign (SSC) was launched in 2002 as a collaborative initiative of three international organizations. The initial guidelines were published in 2004 and an updated version in 2008. Its objective was, through the development and promulgation of evidence-based guidelines that facilitated the application of knowledge derived from clinical trials to bedside practice, to effect a 25% reduction in the relative risk of death from severe sepsis and septic shock [<xref rid="CIT0005" ref-type="bibr">5</xref>, <xref rid="CIT0006" ref-type="bibr">6</xref>]. The development and publication of guidelines often do not lead to changes in clinical behaviour and guidelines are rarely, if ever, integrated into bedside practice in a timely fashion. The SSC undertook a broad educational programme to implement them by integrating their recommendations into resuscitation and management bundles. The feasibility of implementing severe sepsis bundles was validated in the United States, Europe and South America and as a result the mortality from severe sepsis was reduced [<xref rid="CIT0007" ref-type="bibr">7</xref>&#x02013;<xref rid="CIT0019" ref-type="bibr">19</xref>]. Compliance with the bundles and its impact were heterogeneous among institutions and countries [<xref rid="CIT0020" ref-type="bibr">20</xref>]. Therefore, the primary evidence obtained so far lacks enough substance and quality to promote the guidelines as a global standard of care for universal applicability. Further evaluations and primary studies are still needed [<xref rid="CIT0021" ref-type="bibr">21</xref>], especially in countries with limited resources.</p><p>There has only been one report so far in English of compliance with the bundles in Asia [<xref rid="CIT0022" ref-type="bibr">22</xref>]. The study did not aim to evaluate the impact of the sepsis protocol during a one-month observation period. As the centres included in this study might not be fully representative, achievement rates reported might overestimate or underestimate the true degree of compliance with recommended care and should be interpreted with caution. On the other hand, the healthcare systems in many Asian countries differ greatly from those in the above-mentioned developed countries. Therefore, further studies are still warranted in Asia.</p><p>Pneumonia is the major source of infection in severe sepsis patients in our respiratory ICU (RICU). Therefore, we decided to study this population. Adult patients who suffered from severe CAP with severe sepsis or septic shock were enrolled in this study to determine compliance with severe sepsis bundles and to report its effect on patient outcomes in a limited resources country.</p></sec><sec sec-type="materials|methods" id="S0002"><title>Material and methods</title><sec id="S20003"><title>Design and setting</title><p>A prospective observational cohort study from 1 November 2006 to 31 July 2008 was carried out on adult patients who met criteria for severe CAP with severe sepsis or septic shock presenting to the RICU in a Chinese affiliated tertiary hospital of a medical college. Similar patients presenting between 1 November 2004 and 31 October 2006 were used as historical controls.</p></sec><sec id="S20004"><title>Criteria for enrolment</title><p>The CAP was defined as an acute infection of the pulmonary parenchyma associated with an acute infiltrate on the chest radiograph with two or more symptoms including fever (&#x0003e; 38&#x000b0;C), hypothermia (&#x0003c; 36&#x000b0;C), rigors, sweats, new cough or change in colour of respiratory secretions, chest discomfort or dyspnoea. Severe CAP with severe sepsis or septic shock was defined when one of two major criteria (the need for invasive mechanical ventilation or vasopressors) was fulfilled. Septic shock was defined as systolic arterial pressure (SAP) &#x0003c; 90 mm Hg, mean arterial pressure (MAP) &#x0003c; 60 mm Hg, or a reduction in SAP of &#x0003e; 40 mm Hg from baseline, which was persistent, despite adequate fluid resuscitation, in the absence of other causes for hypotension [<xref rid="CIT0003" ref-type="bibr">3</xref>, <xref rid="CIT0023" ref-type="bibr">23</xref>, <xref rid="CIT0024" ref-type="bibr">24</xref>].</p><p>Exclusion criteria were patients who: a) had a cardiac arrest, or b) had end-stage chronic disease (malignancy, chronic renal failure, chronic obstructive pulmonary disease, or acquired immune deficiency syndrome). Patients with severe heart failure, with neoplastic disease (but not in the end stage), with severe asthma, with chronic renal failure stage I, or with brain stroke were also enrolled.</p></sec><sec id="S20005"><title>Components of severe sepsis bundles</title><p>Six-hour and 24-hour severe sepsis bundles adapted from the SSC standard sepsis resuscitation and management bundles are listed in <xref ref-type="table" rid="T0001">Table I</xref> [<xref rid="CIT0025" ref-type="bibr">25</xref>]. Since the use of recombinant human activated protein C is not approved in China, it was eliminated from the 24-hour severe sepsis bundle.
</p><table-wrap id="T0001" position="float"><label>Table I</label><caption><p>Severe sepsis bundles</p></caption><table frame="border" rules="rows" width="100%"><tbody><tr><td align="left" rowspan="1" colspan="1">
<italic><bold>6-hour severe sepsis bundle:</bold></italic>
<list list-type="order"><list-item><p>Serum lactate measured.</p></list-item><list-item><p>Blood cultures obtained prior to antibiotic administration.</p></list-item><list-item><p>Initial empirical antibiotics administered within 1 h.</p></list-item><list-item><p>In the event of hypotension and/or serum lactate &#x0003e; 4 mmol/l:<list list-type="alpha-lower"><list-item><p>Deliver an initial minimum of 20 ml/kg of crystalloid (or colloid equivalent: 1.1 ml/kg of 20% albumin or 4.8 ml/kg of 6% hydroxyethyl starch).</p></list-item><list-item><p>Apply vasopressors (noradrenaline or dopamine) for hypotension not responding to initial fluid resuscitation to maintain mean arterial pressure (MAP) &#x02265; 65 mm Hg.</p></list-item></list>
</p></list-item><list-item><p>In the event of persistent septic shock and/or serum lactate &#x0003e; 4 mmol/l, administration of inotropic dobutamine and/or transfusion of packed red blood cells (when haemoglobin (Hb) &#x0003c; 70 g/l) to achieve a central venous pressure (CVP) of &#x02265; 8 mm Hg and central venous oxygen saturation (ScvO<sub>2</sub>) of &#x02265; 70%.</p></list-item></list>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic><bold>24-hour severe sepsis bundle:</bold></italic>
<list list-type="order"><list-item><p>Low dosage corticosteroid (40&#x02013;60 mg/day of methylprednisolone) administered for septic shock requiring continued infusion of vasopressors.</p></list-item><list-item><p>Glucose control maintained &#x0003c; 8.3 mmol/l.</p></list-item><list-item><p>For mechanically ventilated patients maintain inspiratory plateau pressures &#x0003c; 30 cm H<sub>2</sub>O.</p></list-item></list>
</td></tr></tbody></table></table-wrap></sec><sec id="S20006"><title>Implementation of severe sepsis bundles</title><p>The 21-month implementation programme was organized into two continuous phases that incorporated education and intervention. During the education phase (in November 2006), conference lectures were delivered to all physicians and nurses in the RICU and the emergence department (ED) on the SSC, severe CAP definitions and recognition, haemodynamic monitoring, and the initiation and components of the bundles. Timely initiation and completion of the bundles were emphasized. Time zero was defined as the point when the diagnosis of severe CAP was established in the ED. Serum lactate measured, blood cultures obtained prior to antibiotic administration, and initial empirical antibiotics administered within 1 h were considered once severe CAP was diagnosed, and the admission was fulfilled through an Emergency Path. Insulin was intravenously administered by infusion pump to maintain blood glucose level &#x0003c; 8.3 mmol/l. In the intervention phase (between 1 December 2006 and 31 July 2008), the personnel were issued with a personal pocket information card as a daily reminder of the processes involved in the delivery of the bundles and weekly feedback was provided by the senior physicians to all personnel in order to optimize compliance. The feedback incorporated oral information, cards posted in the RICU and the ED, and group discussions.</p></sec><sec id="S20007"><title>Definition of total compliance</title><p>On the basis of severity of illness, implementation of all necessary components of 6-hour, 24-hour, or 6/24-hour severe sepsis bundles was defined as total compliance. Had some components been unnecessary on the basis of the SSC, a patient would still have been regarded as receiving all components as long as the remaining ones were implemented.</p></sec><sec id="S20008"><title>Approval of study design</title><p>The study was approved by our Institutional Review Boards (Review Board of Guangdong Medical College and Review Board of Guangzhou Medical University). Ethical approval from the regulation committee (Ethical Committee of Guangzhou) was granted for the study protocol with a waiver of informed consent.</p></sec><sec id="S20009"><title>Outcomes</title><p>The primary outcomes were compliance and hospital mortality. Secondary outcomes incorporated ventilator-free days estimated from the ICU length of stay and parameters at 72 h after start of therapy. The endpoints for evaluation were referred to Kortgen's study [<xref rid="CIT0009" ref-type="bibr">9</xref>]. Laboratory variables were measured by the hospital clinical laboratory.</p></sec><sec id="S20010"><title>Grouping and data collection</title><p>One hundred and thirteen patients were enrolled in the cohort study period. Seven cases were excluded from this study according to the exclusion criteria. The remaining 106 patients, 46 (43.4%) patients who suffered from septic, shock were enrolled in the bundles group, which was further divided into the compliant and the non-compliant subgroups at the end of the study according to total compliance with 6/24-hour severe sepsis bundles. One hundred and six discharged patients who were selected through the formal case-control method to match all baseline characteristics of the patients in the prospective group were assigned to the control group. A senior physician was in charge of collecting the data. Demographics, co-morbid conditions, vital signs, laboratory data, and compliance data were collected. The volumes of 6% hydroxyethyl starch and 20% albumin were converted into equivalent dosages of crystalloid [<xref rid="CIT0026" ref-type="bibr">26</xref>]. Severity-of-illness scores were calculated, including the acute physiology and chronic health evaluation (APACHE) II scores and sequential organ failure assessment (SOFA) scores. Missing values were assumed to be normal [<xref rid="CIT0027" ref-type="bibr">27</xref>]. Indeed, patients with less severe illness were more likely to have missing values for laboratory findings. The statistician was blinded to the study and study hypothesis.</p></sec><sec id="S20011"><title>Statistical analysis</title><p>All statistical analyses were performed with Statistical Package for the Social Science for Windows version 13.0 (SPSS, Chicago, IL, USA). Categorical variables and continuous data were reported as percentages and mean &#x000b1; standard deviation (SD), respectively. Chi-square (&#x003c7;<sup>2</sup>) test and independent-samples <italic>t</italic> test were used when appropriate in testing for differences between groups. Univariate and multivariate logistic regression analyses were employed. All components of severe sepsis bundles were entered into a multivariate logistic regression model. Statistical significance was defined as <italic>p</italic> &#x0003c; 0.05.</p></sec></sec><sec sec-type="results" id="S0012"><title>Results</title><sec id="S20013"><title>Baseline characteristics of patients</title><p>No significant differences were observed between the two patient groups with respect to baseline characteristics (<xref ref-type="table" rid="T0002">Table II</xref>). The aetiologies were not detected in many patients in the control group. Hence, the data were not shown. The initial antibiotic regimens in the two groups were consistent with the guidelines on the management of CAP [<xref rid="CIT0003" ref-type="bibr">3</xref>, <xref rid="CIT0028" ref-type="bibr">28</xref>], in addition to subsequently cultured pathogens. All patients in the bundles group had central venous pressure (CVP) and central venous oxygen saturation (ScvO<sub>2</sub>) measured and the averages were 9.4 &#x000b1;1.7 mm Hg and 68.3 &#x000b1;9.8%, respectively. However, these parameters were not measured in most patients in the control group. Therefore, the comparison could not be drawn.
</p><table-wrap id="T0002" position="float"><label>Table II</label><caption><p>Baseline characteristics of patients (mean &#x000b1; SD, <italic>n</italic> = 212)</p></caption><table frame="border" rules="rows" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1">Variable</th><th align="center" rowspan="1" colspan="1">Control group</th><th align="center" rowspan="1" colspan="1">Bundles group</th><th align="center" rowspan="1" colspan="1">Value of &#x003c7;<sup>2</sup> or <italic>t</italic>
</th><th align="center" rowspan="1" colspan="1">Value of <italic>p</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age [years]</td><td align="center" rowspan="1" colspan="1">62.8 &#x000b1;14.2</td><td align="center" rowspan="1" colspan="1">64.0 &#x000b1;15.2</td><td align="center" rowspan="1" colspan="1">0.941</td><td align="center" rowspan="1" colspan="1">0.348</td></tr><tr><td align="left" rowspan="1" colspan="1">Male sex (%)</td><td align="center" rowspan="1" colspan="1">77.4</td><td align="center" rowspan="1" colspan="1">66.1</td><td align="center" rowspan="1" colspan="1">3.347</td><td align="center" rowspan="1" colspan="1">0.067</td></tr><tr><td align="left" rowspan="1" colspan="1">Body temperature [&#x000b0;C]</td><td align="center" rowspan="1" colspan="1">37.6 &#x000b1;1.0</td><td align="center" rowspan="1" colspan="1">37.8 &#x000b1;1.3</td><td align="center" rowspan="1" colspan="1">1.485</td><td align="center" rowspan="1" colspan="1">0.149</td></tr><tr><td align="left" rowspan="1" colspan="1">Heart rate [beats/min]</td><td align="center" rowspan="1" colspan="1">113.6 &#x000b1;22.4</td><td align="center" rowspan="1" colspan="1">116.4 &#x000b1;27.6</td><td align="center" rowspan="1" colspan="1">0.827</td><td align="center" rowspan="1" colspan="1">0.409</td></tr><tr><td align="left" rowspan="1" colspan="1">Respiratory rate [breaths/min]</td><td align="center" rowspan="1" colspan="1">29.0 &#x000b1;6.7</td><td align="center" rowspan="1" colspan="1">29.9 &#x000b1;10.0</td><td align="center" rowspan="1" colspan="1">0.780</td><td align="center" rowspan="1" colspan="1">0.436</td></tr><tr><td align="left" rowspan="1" colspan="1">MAP [mm Hg]</td><td align="center" rowspan="1" colspan="1">81.1 &#x000b1;18.2</td><td align="center" rowspan="1" colspan="1">81.0 &#x000b1;19.9</td><td align="center" rowspan="1" colspan="1">0.035</td><td align="center" rowspan="1" colspan="1">0.972</td></tr><tr><td align="left" rowspan="1" colspan="1">Blood glucose [mmol/l]</td><td align="center" rowspan="1" colspan="1">9.0 &#x000b1;2.6</td><td align="center" rowspan="1" colspan="1">9.1 &#x000b1;3.3</td><td align="center" rowspan="1" colspan="1">0.248</td><td align="center" rowspan="1" colspan="1">0.804</td></tr><tr><td align="left" rowspan="1" colspan="1">White blood cell count [10<sup>9</sup>/l]</td><td align="center" rowspan="1" colspan="1">13.6 &#x000b1;7.5</td><td align="center" rowspan="1" colspan="1">15.0 &#x000b1;6.6</td><td align="center" rowspan="1" colspan="1">1.532</td><td align="center" rowspan="1" colspan="1">0.127</td></tr><tr><td align="left" rowspan="1" colspan="1">PaO<sub>2</sub>/FIO<sub>2</sub> [mm Hg]</td><td align="center" rowspan="1" colspan="1">141.5 &#x000b1;42.9</td><td align="center" rowspan="1" colspan="1">150.2 &#x000b1;58.4</td><td align="center" rowspan="1" colspan="1">1.236</td><td align="center" rowspan="1" colspan="1">0.218</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum creatinine [&#x000b5;mol/l]</td><td align="center" rowspan="1" colspan="1">106.4 &#x000b1;53.9</td><td align="center" rowspan="1" colspan="1">111.7 &#x000b1;79.6</td><td align="center" rowspan="1" colspan="1">0.568</td><td align="center" rowspan="1" colspan="1">0.571</td></tr><tr><td align="left" rowspan="1" colspan="1">Total bilirubin [&#x000b5;mol/l]</td><td align="center" rowspan="1" colspan="1">25.3 &#x000b1;38.9</td><td align="center" rowspan="1" colspan="1">29.0 &#x000b1;69.9</td><td align="center" rowspan="1" colspan="1">0.469</td><td align="center" rowspan="1" colspan="1">0.639</td></tr><tr><td align="left" rowspan="1" colspan="1">Alanine aminotransferase [U/l]</td><td align="center" rowspan="1" colspan="1">88.0 &#x000b1;155.5</td><td align="center" rowspan="1" colspan="1">58.7 &#x000b1;115.0</td><td align="center" rowspan="1" colspan="1">1.559</td><td align="center" rowspan="1" colspan="1">0.121</td></tr><tr><td align="left" rowspan="1" colspan="1">Platelets [10<sup>9</sup>/l]</td><td align="center" rowspan="1" colspan="1">211.7 &#x000b1;108.7</td><td align="center" rowspan="1" colspan="1">205.1 &#x000b1;94.4</td><td align="center" rowspan="1" colspan="1">0.470</td><td align="center" rowspan="1" colspan="1">0.639</td></tr><tr><td align="left" rowspan="1" colspan="1">Haematocrit (%)</td><td align="center" rowspan="1" colspan="1">33.6 &#x000b1;6.4</td><td align="center" rowspan="1" colspan="1">32.9 &#x000b1;6.5</td><td align="center" rowspan="1" colspan="1">0.815</td><td align="center" rowspan="1" colspan="1">0.416</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum lactate [mmol/l]</td><td align="center" rowspan="1" colspan="1">2.8 &#x000b1;1.4</td><td align="center" rowspan="1" colspan="1">3.1 &#x000b1;1.5</td><td align="center" rowspan="1" colspan="1">0.748</td><td align="center" rowspan="1" colspan="1">0.465</td></tr><tr><td align="left" rowspan="1" colspan="1">APACHE II score</td><td align="center" rowspan="1" colspan="1">15.4 &#x000b1;5.3</td><td align="center" rowspan="1" colspan="1">15.9 &#x000b1;7.5</td><td align="center" rowspan="1" colspan="1">0.991</td><td align="center" rowspan="1" colspan="1">0.317</td></tr><tr><td align="left" rowspan="1" colspan="1">SOFA score</td><td align="center" rowspan="1" colspan="1">6.1 &#x000b1;3.4</td><td align="center" rowspan="1" colspan="1">6.9 &#x000b1;4.7</td><td align="center" rowspan="1" colspan="1">1.464</td><td align="center" rowspan="1" colspan="1">0.145</td></tr><tr><td align="left" rowspan="1" colspan="1">Shock (%)</td><td align="center" rowspan="1" colspan="1">37.7</td><td align="center" rowspan="1" colspan="1">43.4</td><td align="center" rowspan="1" colspan="1">0.704</td><td align="center" rowspan="1" colspan="1">0.401</td></tr><tr><td colspan="5" align="left" rowspan="1">Comorbidities (%):</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Hypertension</td><td align="center" rowspan="1" colspan="1">38.4</td><td align="center" rowspan="1" colspan="1">40.6</td><td align="center" rowspan="1" colspan="1">0.265</td><td align="center" rowspan="1" colspan="1">0.529</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Coronary heart disease</td><td align="center" rowspan="1" colspan="1">11.3</td><td align="center" rowspan="1" colspan="1">6.6</td><td align="center" rowspan="1" colspan="1">1.445</td><td align="center" rowspan="1" colspan="1">0.229</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Heart failure</td><td align="center" rowspan="1" colspan="1">12.3</td><td align="center" rowspan="1" colspan="1">10.4</td><td align="center" rowspan="1" colspan="1">0.188</td><td align="center" rowspan="1" colspan="1">0.665</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Chronic obstructive pulmonary disease</td><td align="center" rowspan="1" colspan="1">26.4</td><td align="center" rowspan="1" colspan="1">33.0</td><td align="center" rowspan="1" colspan="1">1.107</td><td align="center" rowspan="1" colspan="1">0.293</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Diabetes mellitus</td><td align="center" rowspan="1" colspan="1">14.2</td><td align="center" rowspan="1" colspan="1">18.9</td><td align="center" rowspan="1" colspan="1">0.856</td><td align="center" rowspan="1" colspan="1">0.355</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Liver disease</td><td align="center" rowspan="1" colspan="1">7.5</td><td align="center" rowspan="1" colspan="1">9.4</td><td align="center" rowspan="1" colspan="1">0.243</td><td align="center" rowspan="1" colspan="1">0.622</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Tumour</td><td align="center" rowspan="1" colspan="1">19.8</td><td align="center" rowspan="1" colspan="1">11.3</td><td align="center" rowspan="1" colspan="1">2.907</td><td align="center" rowspan="1" colspan="1">0.088</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Nervous system disease</td><td align="center" rowspan="1" colspan="1">7.5</td><td align="center" rowspan="1" colspan="1">9.4</td><td align="center" rowspan="1" colspan="1">0.243</td><td align="center" rowspan="1" colspan="1">0.622</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Chronic renal insufficiency</td><td align="center" rowspan="1" colspan="1">7.5</td><td align="center" rowspan="1" colspan="1">5.7</td><td align="center" rowspan="1" colspan="1">0.306</td><td align="center" rowspan="1" colspan="1">0.580</td></tr><tr><td align="left" rowspan="1" colspan="1">Alcohol abuse (%)</td><td align="center" rowspan="1" colspan="1">5.7</td><td align="center" rowspan="1" colspan="1">1.9</td><td align="center" rowspan="1" colspan="1">2.078</td><td align="center" rowspan="1" colspan="1">0.149</td></tr><tr><td align="left" rowspan="1" colspan="1">Smoking (%)</td><td align="center" rowspan="1" colspan="1">34.9</td><td align="center" rowspan="1" colspan="1">35.8</td><td align="center" rowspan="1" colspan="1">0.021</td><td align="center" rowspan="1" colspan="1">0.886</td></tr><tr><td align="left" rowspan="1" colspan="1">Duration to establish severe CAP diagnosis [min]</td><td align="center" rowspan="1" colspan="1">61.8 &#x000b1;57.2</td><td align="center" rowspan="1" colspan="1">60.3 &#x000b1;49.5</td><td align="center" rowspan="1" colspan="1">0.253</td><td align="center" rowspan="1" colspan="1">0.712</td></tr><tr><td colspan="5" align="left" rowspan="1">Antibiotic therapy:</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Antibiotics adequate (%)</td><td align="center" rowspan="1" colspan="1">93.7</td><td align="center" rowspan="1" colspan="1">95.8</td><td align="center" rowspan="1" colspan="1">0.319</td><td align="center" rowspan="1" colspan="1">0.527</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Duration [days]</td><td align="center" rowspan="1" colspan="1">12.6 &#x000b1;14.3</td><td align="center" rowspan="1" colspan="1">12.9 &#x000b1;15.1</td><td align="center" rowspan="1" colspan="1">0.237</td><td align="center" rowspan="1" colspan="1">0.872</td></tr></tbody></table><table-wrap-foot><fn><p>PaO<sub>2</sub>/FIO<sub>2</sub> &#x02013; arterial oxygen pressure/fraction inspired oxygen.</p></fn></table-wrap-foot></table-wrap></sec><sec id="S20014"><title>Compliance with severe sepsis bundles</title><p>Compliance with administration of antibiotics within 1 h, administration of vasopressors (if necessary), and plateau pressure on average &#x0003c; 30 cm H<sub>2</sub>O was high in both groups (<italic>p</italic>, 0.206, 0.085, 0.149, respectively; <xref ref-type="fig" rid="F0001">Figure 1</xref>). Significant differences were found between the two groups with respect to serum lactate measured, blood cultures obtained prior to antibiotic administration, initiation of fluid resuscitation and volumes infused, administration of inotropic dobutamine and/or transfusion of packed red blood cells, low-dose steroids (if necessary), and glucose control (<italic>p</italic>, &#x0003c; 0.001, 0.001, &#x0003c; 0.001, 0.005, &#x0003c; 0.001, and &#x0003c; 0.001, respectively; <xref ref-type="fig" rid="F0001">Figure 1</xref>). Inotropic dobutamine was administered to 17 patients, 11 patients simultaneously received an average 4-unit transfusion of packed red cells in the bundles group, whereas the numbers in the control group were 4, 2, and 2, respectively. The average volume infused within 6 h in the bundles group was more than that in the control group (1319.8 &#x000b1;1107.4 ml vs. 461.9 &#x000b1;799.3 ml; <italic>p</italic> &#x0003c; 0.001). The rates of total compliance with 6-hour, 24-hour, and 6/24-hour bundles in the bundles group were 47.1%, 51.9%, and 42.5%, whereas the rates in the control group were 0.0%, 0.0%, and 0.0% (<italic>p</italic>, &#x0003c; 0.001, &#x0003c; 0.001, and &#x0003c; 0.001), respectively.</p><fig id="F0001" position="float"><label>Figure 1</label><caption><p>Compliance with components of severe sepsis bundles (<italic>n</italic> = 212)</p><p>RBC &#x02013; red blood cells</p></caption><graphic xlink:href="AMS-10-23761-g001"/></fig></sec><sec id="S20015"><title>Outcomes at 72 hours</title><p>Significant differences were observed between the two groups in respiratory rate, MAP, blood glucose, arterial oxygen pressure/fraction inspired oxygen (PaO<sub>2</sub>/FIO<sub>2</sub>), serum creatinine, serum lactate, APACHE II scores, and SOFA scores at 72 h after the start of therapy (<xref ref-type="table" rid="T0003">Table III</xref>). Central venous pressure increased significantly from 9.4 &#x000b1;1.7 mm Hg at baseline to 10.9 &#x000b1;1.8 mm Hg at 72 h after the start of therapy in the bundles group (<italic>p</italic> &#x0003c; 0.001), as did ScvO<sub>2</sub> during this time period (68.3 &#x000b1;9.8% vs. 79.5 &#x000b1;3.8%, <italic>p</italic> &#x0003c; 0.001).
</p><table-wrap id="T0003" position="float"><label>Table III</label><caption><p>Outcomes at 72 h (mean &#x000b1; SD, <italic>n</italic> = 212)</p></caption><table frame="border" rules="rows" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1">Parameter</th><th align="center" rowspan="1" colspan="1">Control group</th><th align="center" rowspan="1" colspan="1">Bundles group</th><th align="center" rowspan="1" colspan="1">Value of <italic>t</italic>
</th><th align="center" rowspan="1" colspan="1">Value of <italic>p</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Body temperature [&#x000b0;C]</td><td align="center" rowspan="1" colspan="1">37.2 &#x000b1;1.0</td><td align="center" rowspan="1" colspan="1">37.3 &#x000b1;0.9</td><td align="center" rowspan="1" colspan="1">0.236</td><td align="center" rowspan="1" colspan="1">0.814</td></tr><tr><td align="left" rowspan="1" colspan="1">Heart rate [beats/min]</td><td align="center" rowspan="1" colspan="1">100.3 &#x000b1;21.5</td><td align="center" rowspan="1" colspan="1">99.7 &#x000b1;17.5</td><td align="center" rowspan="1" colspan="1">0.214</td><td align="center" rowspan="1" colspan="1">0.831</td></tr><tr><td align="left" rowspan="1" colspan="1">Respiratory rate [breaths/min]</td><td align="center" rowspan="1" colspan="1">27.7 &#x000b1;7.0</td><td align="center" rowspan="1" colspan="1">25.2 &#x000b1;7.6</td><td align="center" rowspan="1" colspan="1">2.542</td><td align="center" rowspan="1" colspan="1">0.012</td></tr><tr><td align="left" rowspan="1" colspan="1">MAP [mm Hg]</td><td align="center" rowspan="1" colspan="1">87.8 &#x000b1;12.9</td><td align="center" rowspan="1" colspan="1">91.4 &#x000b1;10.6</td><td align="center" rowspan="1" colspan="1">2.185</td><td align="center" rowspan="1" colspan="1">0.030</td></tr><tr><td align="left" rowspan="1" colspan="1">Blood glucose [mmol/l]</td><td align="center" rowspan="1" colspan="1">8.9 &#x000b1;2.3</td><td align="center" rowspan="1" colspan="1">7.4 &#x000b1;1.8</td><td align="center" rowspan="1" colspan="1">5.360</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">White blood cell count [10<sup>9</sup>/l]</td><td align="center" rowspan="1" colspan="1">13.0 &#x000b1;8.9</td><td align="center" rowspan="1" colspan="1">14.2 &#x000b1;7.5</td><td align="center" rowspan="1" colspan="1">1.034</td><td align="center" rowspan="1" colspan="1">0.302</td></tr><tr><td align="left" rowspan="1" colspan="1">PaO<sub>2</sub>/FIO<sub>2</sub> [mm Hg]</td><td align="center" rowspan="1" colspan="1">172.4 &#x000b1;101.6</td><td align="center" rowspan="1" colspan="1">223.1 &#x000b1;83.3</td><td align="center" rowspan="1" colspan="1">3.971</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum creatinine [&#x000b5;mol/l]</td><td align="center" rowspan="1" colspan="1">118.3 &#x000b1;87.5</td><td align="center" rowspan="1" colspan="1">97.0 &#x000b1;52.6</td><td align="center" rowspan="1" colspan="1">2.145</td><td align="center" rowspan="1" colspan="1">0.033</td></tr><tr><td align="left" rowspan="1" colspan="1">Total bilirubin [&#x000b5;mol/l]</td><td align="center" rowspan="1" colspan="1">33.7 &#x000b1;64.9</td><td align="center" rowspan="1" colspan="1">35.7 &#x000b1;98.9</td><td align="center" rowspan="1" colspan="1">0.179</td><td align="center" rowspan="1" colspan="1">0.858</td></tr><tr><td align="left" rowspan="1" colspan="1">Alanine aminotransferase [U/l]</td><td align="center" rowspan="1" colspan="1">254.8 &#x000b1;1219.2</td><td align="center" rowspan="1" colspan="1">51.2 &#x000b1;50.9</td><td align="center" rowspan="1" colspan="1">1.718</td><td align="center" rowspan="1" colspan="1">0.087</td></tr><tr><td align="left" rowspan="1" colspan="1">Platelets [10<sup>9</sup>/l]</td><td align="center" rowspan="1" colspan="1">159.6 &#x000b1;109.8</td><td align="center" rowspan="1" colspan="1">162.0 &#x000b1;112.3</td><td align="center" rowspan="1" colspan="1">0.161</td><td align="center" rowspan="1" colspan="1">0.872</td></tr><tr><td align="left" rowspan="1" colspan="1">Haematocrit (%)</td><td align="center" rowspan="1" colspan="1">30.7 &#x000b1;5.4</td><td align="center" rowspan="1" colspan="1">29.8 &#x000b1;5.3</td><td align="center" rowspan="1" colspan="1">1.229</td><td align="center" rowspan="1" colspan="1">0.221</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum lactate [mmol/l]</td><td align="center" rowspan="1" colspan="1">4.1 &#x000b1;3.9</td><td align="center" rowspan="1" colspan="1">2.5 &#x000b1;0.7</td><td align="center" rowspan="1" colspan="1">2.979</td><td align="center" rowspan="1" colspan="1">0.004</td></tr><tr><td align="left" rowspan="1" colspan="1">APACHE II score</td><td align="center" rowspan="1" colspan="1">11.3 &#x000b1;5.7</td><td align="center" rowspan="1" colspan="1">9.5 &#x000b1;4.7</td><td align="center" rowspan="1" colspan="1">2.637</td><td align="center" rowspan="1" colspan="1">0.009</td></tr><tr><td align="left" rowspan="1" colspan="1">SOFA score</td><td align="center" rowspan="1" colspan="1">6.6 &#x000b1;4.1</td><td align="center" rowspan="1" colspan="1">5.4 &#x000b1;4.3</td><td align="center" rowspan="1" colspan="1">2.170</td><td align="center" rowspan="1" colspan="1">0.031</td></tr></tbody></table></table-wrap></sec><sec id="S20016"><title>Hospital mortality and ventilator-free days</title><p>Hospital mortality in patients enrolled in the bundles group compared with that in the control group was 29.2% vs. 44.3% (&#x003c7;<sup>2</sup> = 5.192, <italic>p</italic> = 0.023), reflecting a 15.1% absolute reduction in mortality. There was a significantly decreased odds ratio (OR) for mortality in patients who received bundles treatment (OR = 0.393; 95% confidence interval (CI), 0.209&#x02013;0.741; <italic>p</italic> = 0.004). A multivariate logistic regression analysis was performed. Serum lactate measured, blood cultures obtained prior to antibiotic administration, and fluid resuscitation showed independent relationships with decreased mortality (OR = 0.112, 0.459, and 0.247; 95% CI: 0.037&#x02013;0.334, 0.211&#x02013;0.997, and 0.091&#x02013;0.635; <italic>p</italic>, &#x0003c; 0.001, 0.039, and &#x0003c; 0.001; respectively).</p><p>The two subgroups were comparable with respect to age, gender, and severity at baseline (<xref ref-type="table" rid="T0004">Table IV</xref>). Compared with the non-compliant subgroup, the compliant subgroup had a more than twofold decrease in mortality (17.8% vs. 37.7%. OR = 0.222; 95% CI: 0.082&#x02013;0.602; <italic>p</italic> = 0.003).
</p><table-wrap id="T0004" position="float"><label>Table IV</label><caption><p>Baseline characteristics of patients and mortality in the bundles group according to total compliance (mean &#x000b1; SD, <italic>n</italic> = 106)</p></caption><table frame="border" rules="rows" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1">Parameter</th><th align="center" rowspan="1" colspan="1">Compliant subgroup (<italic>n</italic> = 45)</th><th align="center" rowspan="1" colspan="1">Non-compliant subgroup (<italic>n</italic> = 61)</th><th align="center" rowspan="1" colspan="1">Value of &#x003c7;<sup>2</sup> or <italic>t</italic>
</th><th align="center" rowspan="1" colspan="1">Value of <italic>p</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age [years]</td><td align="center" rowspan="1" colspan="1">61.7 &#x000b1;19.2</td><td align="center" rowspan="1" colspan="1">61.4 &#x000b1;15.5</td><td align="center" rowspan="1" colspan="1">0.096</td><td align="center" rowspan="1" colspan="1">0.924</td></tr><tr><td align="left" rowspan="1" colspan="1">Male sex (%)</td><td align="center" rowspan="1" colspan="1">68.9</td><td align="center" rowspan="1" colspan="1">63.9</td><td align="center" rowspan="1" colspan="1">0.283</td><td align="center" rowspan="1" colspan="1">0.594</td></tr><tr><td align="left" rowspan="1" colspan="1">MAP [mm Hg]</td><td align="center" rowspan="1" colspan="1">81.6 &#x000b1;21.0</td><td align="center" rowspan="1" colspan="1">80.5 &#x000b1;19.2</td><td align="center" rowspan="1" colspan="1">0.289</td><td align="center" rowspan="1" colspan="1">0.773</td></tr><tr><td align="left" rowspan="1" colspan="1">White blood cell count [10<sup>9</sup>/l]</td><td align="center" rowspan="1" colspan="1">16.5 &#x000b1;7.4</td><td align="center" rowspan="1" colspan="1">14.0 &#x000b1;5.7</td><td align="center" rowspan="1" colspan="1">1.926</td><td align="center" rowspan="1" colspan="1">0.048</td></tr><tr><td align="left" rowspan="1" colspan="1">PaO<sub>2</sub>/FIO<sub>2</sub> [mm Hg]</td><td align="center" rowspan="1" colspan="1">145.3 &#x000b1;63.2</td><td align="center" rowspan="1" colspan="1">162.1 &#x000b1;52.2</td><td align="center" rowspan="1" colspan="1">1.460</td><td align="center" rowspan="1" colspan="1">0.148</td></tr><tr><td align="left" rowspan="1" colspan="1">APACHE II score</td><td align="center" rowspan="1" colspan="1">16.9 &#x000b1;7.3</td><td align="center" rowspan="1" colspan="1">15.2 &#x000b1;7.6</td><td align="center" rowspan="1" colspan="1">1.206</td><td align="center" rowspan="1" colspan="1">0.231</td></tr><tr><td align="left" rowspan="1" colspan="1">SOFA score</td><td align="center" rowspan="1" colspan="1">7.4 &#x000b1;5.3</td><td align="center" rowspan="1" colspan="1">6.0 &#x000b1;4.0</td><td align="center" rowspan="1" colspan="1">1.470</td><td align="center" rowspan="1" colspan="1">0.146</td></tr><tr><td align="left" rowspan="1" colspan="1">Shock (%)</td><td align="center" rowspan="1" colspan="1">44.4</td><td align="center" rowspan="1" colspan="1">31.1</td><td align="center" rowspan="1" colspan="1">1.969</td><td align="center" rowspan="1" colspan="1">0.161</td></tr><tr><td align="left" rowspan="1" colspan="1">Mortality, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1">8 (17.8)</td><td align="center" rowspan="1" colspan="1">23 (37.7)</td><td align="center" rowspan="1" colspan="1">4.970</td><td align="center" rowspan="1" colspan="1">0.026</td></tr></tbody></table></table-wrap><p>All patients in both groups were mechanically ventilated. In the bundles group, patients had significant longer ventilator-free days compared with such patients in the control group (6.1 &#x000b1;6.7 vs. 3.9 &#x000b1; 6.6 days; <italic>p</italic> = 0.017).</p></sec></sec><sec sec-type="discussion" id="S0017"><title>Discussion</title><p>Compliance with administration of antibiotics and vasopressors and plateau pressure on average &#x0003c; 30 cm H<sub>2</sub>O was high. The rates of total compliance with the bundles in the prospective period increased significantly. Hospital mortalities were significantly reduced in the bundles group and in the compliant subgroup. Serum lactate measurement, blood cultures, and fluid resuscitation were independently associated with decreased mortality.</p><p>Initial empirical antibiotics were generally administered within 1 h, suggesting that our physicians know and readily accept the concept of the association between timing of antibiotic administration and outcomes [<xref rid="CIT0029" ref-type="bibr">29</xref>&#x02013;<xref rid="CIT0031" ref-type="bibr">31</xref>]. Nguyen <italic>et al</italic>. [<xref rid="CIT0032" ref-type="bibr">32</xref>] found that physicians were more willing to accept hypotension than serum lactate concentration as a criterion to initiate resuscitation, as in the current study; that is to say, some patients with serum lactate &#x0003e; 4 mmol/l might not receive fluid resuscitation. Therefore, compliance with initiation of fluid resuscitation was not high. Compliance with administration of vasopressors was high in both groups, but the implementation of administration of inotropic dobutamine and/or transfusion of packed red blood cells was poor (the worst), suggesting that our physicians did not put more emphasis on the imbalance between oxygen consumption and supply when dealing with persistent septic shock. Glucose control was the lowest compliant element of the 24-hour bundle in our study despite continuous insulin infusion. Scrupulous avoidance of iatrogenic hypoglycaemia frequently resulted in blood glucose &#x0003e; 8.3 mmol/l.</p><p>Our physicians found that weekly feedback facilitated the implementation of the bundles. Levy <italic>et al</italic>.
[<xref rid="CIT0013" ref-type="bibr">13</xref>] also reported that compliance with the entire resuscitation bundle and with the entire management bundle increased to 31.3% and 36.1%, respectively, by the end of 2 years. The compliance rate with all elements of the sepsis resuscitation bundle increased from 12.7% at baseline to 37.7% and 53.7% during the weekly feedback and sepsis response team activation periods, respectively (<italic>p</italic> &#x0003c; 0.001) [<xref rid="CIT0033" ref-type="bibr">33</xref>]. Compliance with a 6-hour severe sepsis bundle at the beginning was low and increased by the end (from 8.1% to 53.7%) [<xref rid="CIT0008" ref-type="bibr">8</xref>].</p><p>The total compliance was not high in the current study, as was it in Phua's study (compliance rates for the resuscitation and management bundles were 7.6% and 3.5%, respectively) [<xref rid="CIT0022" ref-type="bibr">22</xref>] and Schramm's study (the compliance rate with all elements of the sepsis resuscitation bundle increased from 12.7% at baseline to 37.7% and 53.7% during the weekly feedback and sepsis response team activation periods, respectively) [<xref rid="CIT0033" ref-type="bibr">33</xref>]. Two of the major factors limiting high total compliance in our study might be lack of sufficient staff in the RICU and the ED and difficulty in maintaining the time intervals. This is likely to be improved by better staff awareness of the benefits and timeliness of implementing the bundles. Levy's report emphasized the importance of early management and was reminiscent of the concept of the golden 6 h and silver 24 h for trauma [<xref rid="CIT0034" ref-type="bibr">34</xref>].</p><p>The SSC has had some impact; however, there is still a long way to go [<xref rid="CIT0035" ref-type="bibr">35</xref>]. What about the feasibility of implementing the bundles in undeveloped countries? Our institution is the state key laboratory of respiratory diseases. This might be envisaged to interpret the higher compliance in the current study, compared with that in Phua's multicentre study [<xref rid="CIT0022" ref-type="bibr">22</xref>]. It is likely to imply that the implementation of the bundles might be very arduous in many undeveloped countries, especially those in Asia. This might be an important message that would have potential to improve care on a global basis. Hence, future long-term multicentre studies should be performed to assess the compliance in limited resources countries.</p><p>The patients without hypotension would still have received fluid resuscitation had serum lactate been measured, which could be of survival benefit. Similarly, obtaining blood cultures may be useful if the blood cultures revealed a pathogen that was not being treated effectively with the antibiotics chosen. If the clinician was then able to act upon that information and correct the antibiotic choice, this could have an impact on mortality. These considerations might explain why serum lactate measured and blood cultures showed independent relationships with decreased mortality.</p><p>Our current data revealed the pivotal role of implementing severe sepsis bundles in the management of severe CAP. The 15.1% absolute hospital mortality reduction in our study was similar to that reported by Nguyen <italic>et al</italic>. (18.7%) [<xref rid="CIT0008" ref-type="bibr">8</xref>], Kortgen <italic>et al</italic>. (26%) [<xref rid="CIT0009" ref-type="bibr">9</xref>], Micek <italic>et al</italic>. (18.3%) [<xref rid="CIT0011" ref-type="bibr">11</xref>], Lefrant <italic>et al</italic>. (13.0%) [<xref rid="CIT0016" ref-type="bibr">16</xref>], Schramm <italic>et al</italic>. (8.3%) [<xref rid="CIT0033" ref-type="bibr">33</xref>], and Castellanos-Ortega <italic>et al</italic>. (19.8%) [<xref rid="CIT0036" ref-type="bibr">36</xref>]. In the compliant subgroup, patients had a more than twofold decrease in mortality compared with such patients in the non-compliant subgroup in the current study. Gao <italic>et al</italic>.
[<xref rid="CIT0007" ref-type="bibr">7</xref>] reported that the mortality in the compliant group decreased from 49% to 23% (<italic>p</italic> = 0.01), compared with the non-compliant group. Mortality was 61.1% in the non-bundle group versus 20% with the bundle (<italic>p</italic> &#x0003c; 0.001) [<xref rid="CIT0015" ref-type="bibr">15</xref>]. Delivery of the interventions had an association with reduced mortality: for the sepsis six, 20.0% compared with 44.1% (<italic>p</italic> &#x0003c; 0.001); for the resuscitation bundle, 5.9% compared with 51% (<italic>p</italic> &#x0003c; 0.001) [<xref rid="CIT0014" ref-type="bibr">14</xref>].</p><p>Several limitations of this study deserve comment. Comparing crude mortality rates before and after an intervention ignores the underlying trend of decreased mortality and might give rise to misleading conclusions. Another limitation is that it was performed only in patients with severe CAP and not other types of sepsis from other sources of infection such as intra-abdominal infections or soft tissue infections. There might be some imbalance in the aetiology of pneumonia between the two groups. The study was not multicentre. Finally, long-term follow-up was not done; therefore, it was uncertain whether the implementation of the bundles and its effect would be similar to what Ferrer <italic>et al</italic>. [<xref rid="CIT0037" ref-type="bibr">37</xref>] reported (during long-term follow-up, compliance with the sepsis resuscitation bundle returned to baseline but compliance with the sepsis management bundle and mortality remained stable with respect to the post-intervention period).</p><p>In conclusion, total compliance was relatively low, but the implementation of severe sepsis bundles was associated with a significant decrease in mortality from severe CAP.</p></sec></body><back><ack><title>Acknowledgments</title><p>Qi Guo and Hai-Yan Li are joint first authors.</p><p>The study was funded by the nonprofit foundation of Ying-Dong Huo in Hongkong.</p><p>Part of the data was accepted for presentation (Number: P2999) in the Thematic Poster session entitled &#x0201c;Etiology of lower respiratory tract infections and treatment in special situations&#x0201d; at the ERS (European Respiratory Society) Barcelona 2010 Annual Congress (18&#x02013;22 September).</p><p>Q.G, H-Y.L, Y-M.L, Z-L.X and N-S.Z made substantial contributions to the conception and design. Q.G and H-Y.L were in charge of data collection and wrote the manuscript. Y-M.L, L-B.N, Y-D.X, G-Q.H, and X-Q.L made substantial contributions to acquisition of data. M.J was in charge of statistical analysis. Z-L.X and N-S.Z were involved in general supervision of the research group.</p><p>We are indebted to the staffing of the ED, and nurses and postgraduates of the RICU for making contributions to this study.</p><p>We thank Chris J. Corrigan (King's College London) for assistance in English editing.</p></ack><ref-list><title>References</title><ref id="CIT0001"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feikin</surname><given-names>DR</given-names></name><name><surname>Schuchat</surname><given-names>A</given-names></name><name><surname>Kolczak</surname><given-names>M</given-names></name><etal/></person-group><article-title>Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997</article-title><source>Am J Public Health</source><year>2000</year><volume>90</volume><fpage>223</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">10667183</pub-id></element-citation></ref><ref id="CIT0002"><label>2</label><element-citation publication-type="journal"><collab>American Thoracic Society; Infectious Diseases Society of America</collab><article-title>Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia</article-title><source>Am J Respir Crit Care Med</source><year>2005</year><volume>171</volume><fpage>388</fpage><lpage>416</lpage><pub-id pub-id-type="pmid">15699079</pub-id></element-citation></ref><ref id="CIT0003"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandell</surname><given-names>LA</given-names></name><name><surname>Wunderink</surname><given-names>RG</given-names></name><name><surname>Anzueto</surname><given-names>A</given-names></name><etal/></person-group><article-title>Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults</article-title><source>Clin Infect Dis</source><year>2007</year><volume>44</volume><issue>Suppl 2</issue><fpage>S27</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">17278083</pub-id></element-citation></ref><ref id="CIT0004"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Restrepo</surname><given-names>MI</given-names></name><name><surname>Anzueto</surname><given-names>A</given-names></name></person-group><article-title>Severe community-acquired pneumonia</article-title><source>Infect Dis Clin North Am</source><year>2009</year><volume>23</volume><fpage>503</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">19665080</pub-id></element-citation></ref><ref id="CIT0005"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dellinger</surname><given-names>RP</given-names></name><name><surname>Carlet</surname><given-names>JM</given-names></name><name><surname>Masur</surname><given-names>H</given-names></name><etal/></person-group><article-title>Surviving sepsis campaign guidelines for management of severe sepsis and septic shock</article-title><source>Crit Care Med</source><year>2004</year><volume>32</volume><fpage>858</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">15090974</pub-id></element-citation></ref><ref id="CIT0006"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dellinger</surname><given-names>RP</given-names></name><name><surname>Levy</surname><given-names>MM</given-names></name><name><surname>Carlet</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock:2008</article-title><source>Crit Care Med</source><year>2008</year><volume>36</volume><fpage>296</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">18158437</pub-id></element-citation></ref><ref id="CIT0007"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>F</given-names></name><name><surname>Melody</surname><given-names>T</given-names></name><name><surname>Daniels</surname><given-names>DF</given-names></name><name><surname>Giles</surname><given-names>S</given-names></name><name><surname>Fox</surname><given-names>S</given-names></name></person-group><article-title>The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study</article-title><source>Crit Care</source><year>2005</year><volume>9</volume><fpage>R764</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">16356225</pub-id></element-citation></ref><ref id="CIT0008"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>HB</given-names></name><name><surname>Corbett</surname><given-names>SW</given-names></name><name><surname>Steele</surname><given-names>R</given-names></name><etal/></person-group><article-title>Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality</article-title><source>Crit Care Med</source><year>2007</year><volume>35</volume><fpage>1105</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">17334251</pub-id></element-citation></ref><ref id="CIT0009"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kortgen</surname><given-names>A</given-names></name><name><surname>Niederpr&#x000fc;m</surname><given-names>P</given-names></name><name><surname>Bauer</surname><given-names>M</given-names></name></person-group><article-title>Implementation of an evidence-based &#x0201c;standard operating procedure&#x0201d; and outcome in septic shock</article-title><source>Crit Care Med</source><year>2006</year><volume>34</volume><fpage>943</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16484902</pub-id></element-citation></ref><ref id="CIT0010"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shapiro</surname><given-names>NI</given-names></name><name><surname>Howell</surname><given-names>MD</given-names></name><name><surname>Talmor</surname><given-names>D</given-names></name><etal/></person-group><article-title>Implementation and outcomes of the Multiple Urgent Sepsis Therapies (MUST) protocol</article-title><source>Crit Care Med</source><year>2006</year><volume>34</volume><fpage>1025</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">16484890</pub-id></element-citation></ref><ref id="CIT0011"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Micek</surname><given-names>ST</given-names></name><name><surname>Roubinian</surname><given-names>N</given-names></name><name><surname>Heuring</surname><given-names>T</given-names></name><etal/></person-group><article-title>Before-after study of a standardized hospital order set for the management of septic shock</article-title><source>Crit Care Med</source><year>2006</year><volume>34</volume><fpage>2707</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">16943733</pub-id></element-citation></ref><ref id="CIT0012"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>AE</given-names></name><name><surname>Focht</surname><given-names>A</given-names></name><name><surname>Horton</surname><given-names>JM</given-names></name><name><surname>Kline</surname><given-names>JA</given-names></name></person-group><article-title>Prospective external validation of the clinical effectiveness of an emergency department-based early goal-directed therapy protocol for severe sepsis and septic shock</article-title><source>Chest</source><year>2007</year><volume>132</volume><fpage>425</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">17573521</pub-id></element-citation></ref><ref id="CIT0013"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>MM</given-names></name><name><surname>Dellinger</surname><given-names>RP</given-names></name><name><surname>Townsend</surname><given-names>SR</given-names></name><etal/></person-group><article-title>The surviving sepsis campaign: results of an international guideline-based performance improvement program targeting severe sepsis</article-title><source>Crit Care Med</source><year>2010</year><volume>38</volume><fpage>367</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">20035219</pub-id></element-citation></ref><ref id="CIT0014"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daniels</surname><given-names>R</given-names></name><name><surname>Nutbeam</surname><given-names>T</given-names></name><name><surname>McNamara</surname><given-names>G</given-names></name><name><surname>Galvin</surname><given-names>C</given-names></name></person-group><article-title>The sepsis six and the severe sepsis resuscitation bundle: a prospective observational cohort study</article-title><source>Emerg Med J</source><year>2011</year><volume>28</volume><fpage>507</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">21036796</pub-id></element-citation></ref><ref id="CIT0015"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>GW</given-names></name><name><surname>Roderman</surname><given-names>N</given-names></name><name><surname>Gehring</surname><given-names>H</given-names></name><name><surname>Saad</surname><given-names>J</given-names></name><name><surname>Bartek</surname><given-names>W</given-names></name></person-group><article-title>Assessing the effect of the surviving sepsis campaign treatment guidelines on clinical outcomes in a community hospital</article-title><source>Ann Pharmacother</source><year>2010</year><volume>44</volume><fpage>1733</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">20978215</pub-id></element-citation></ref><ref id="CIT0016"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefrant</surname><given-names>JY</given-names></name><name><surname>Muller</surname><given-names>L</given-names></name><name><surname>Raillard</surname><given-names>A</given-names></name><etal/></person-group><article-title>Reduction of the severe sepsis or septic shock associated mortality by reinforcement of the recommendations bundle: a multicenter study</article-title><source>Ann Fr Anesth Reanim</source><year>2010</year><volume>29</volume><fpage>621</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">20634026</pub-id></element-citation></ref><ref id="CIT0017"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardoso</surname><given-names>T</given-names></name><name><surname>Carneiro</surname><given-names>AH</given-names></name><name><surname>Ribeiro</surname><given-names>O</given-names></name><name><surname>Teixeira-Pinto</surname><given-names>A</given-names></name><name><surname>Costa-Pereira</surname><given-names>A</given-names></name></person-group><article-title>Reducing mortality in severe sepsis with the implementation of a core 6-hour bundle: results from the Portuguese community-acquired sepsis study (SACiUCI study)</article-title><source>Crit Care</source><year>2010</year><volume>14</volume><fpage>R83</fpage><pub-id pub-id-type="pmid">20459716</pub-id></element-citation></ref><ref id="CIT0018"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pesta&#x000f1;a</surname><given-names>D</given-names></name><name><surname>Espinosa</surname><given-names>E</given-names></name><name><surname>Sang&#x000fc;esa-Molina</surname><given-names>JR</given-names></name><etal/></person-group><article-title>Compliance with a sepsis bundle and its effect on intensive care unit mortality in surgical septic shock patients</article-title><source>J Trauma</source><year>2010</year><volume>69</volume><fpage>1282</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">20134352</pub-id></element-citation></ref><ref id="CIT0019"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiramizo</surname><given-names>SC</given-names></name><name><surname>Marra</surname><given-names>AR</given-names></name><name><surname>Dur&#x000e3;o</surname><given-names>MS</given-names></name><name><surname>Paes</surname><given-names>&#x000c2;T</given-names></name><name><surname>Edmond</surname><given-names>MB</given-names></name><name><surname>Pav&#x000e3;o dos Santos</surname><given-names>OF</given-names></name></person-group><article-title>Decreasing mortality in severe sepsis and septic shock patients by implementing a sepsis bundle in a hospital setting</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><fpage>e26790</fpage><pub-id pub-id-type="pmid">22073193</pub-id></element-citation></ref><ref id="CIT0020"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machado</surname><given-names>FR</given-names></name><name><surname>Mazza</surname><given-names>BF</given-names></name></person-group><article-title>Improving mortality in sepsis: analysis of clinical trials</article-title><source>Shock</source><year>2010</year><volume>34</volume><issue>Suppl. 1</issue><fpage>S54</fpage><lpage>S58</lpage></element-citation></ref><ref id="CIT0021"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finfer</surname><given-names>S</given-names></name></person-group><article-title>The surviving sepsis campaign: robust evaluation and high-quality primary research is still needed</article-title><source>Crit Care Med</source><year>2010</year><volume>38</volume><fpage>683</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">20083922</pub-id></element-citation></ref><ref id="CIT0022"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phua</surname><given-names>J</given-names></name><name><surname>Koh</surname><given-names>Y</given-names></name><name><surname>Du</surname><given-names>B</given-names></name><etal/></person-group><article-title>Management of severe sepsis in patients admitted to Asian intensive care units: prospective cohort study</article-title><source>BMJ</source><year>2011</year><volume>342</volume><fpage>d3245</fpage><pub-id pub-id-type="pmid">21669950</pub-id></element-citation></ref><ref id="CIT0023"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phua</surname><given-names>J</given-names></name><name><surname>See</surname><given-names>KC</given-names></name><name><surname>Chan</surname><given-names>YH</given-names></name><etal/></person-group><article-title>Validation and clinical implications of the IDSA/ATS minor criteria for severe community-acquired pneumonia</article-title><source>Thorax</source><year>2009</year><volume>64</volume><fpage>598</fpage><lpage>603</lpage><pub-id pub-id-type="pmid">19386583</pub-id></element-citation></ref><ref id="CIT0024"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>MM</given-names></name><name><surname>Fink</surname><given-names>MP</given-names></name><name><surname>Marshall</surname><given-names>JC</given-names></name><etal/></person-group><article-title>2001 SCCM/ESICM/ ACCP/ATS/SIS International Sepsis Definitions Conference</article-title><source>Crit Care Med</source><year>2003</year><volume>31</volume><fpage>1250</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">12682500</pub-id></element-citation></ref><ref id="CIT0025"><label>25</label><element-citation publication-type="webpage"><collab>Surviving Sepsis Campaign and Institute for Healthcare Improvement</collab><article-title>Sepsis Bundle</article-title><comment>Available online at: <ext-link ext-link-type="uri" xlink:href="http://www.ihi.org/IHI/Topics/CriticalCare/Sepsis/Tools/SevereSepsisBundle.htm">http://www.ihi.org/IHI/Topics/CriticalCare/Sepsis/Tools/SevereSepsisBundle.htm</ext-link>. Accessed May 26, 2006</comment></element-citation></ref><ref id="CIT0026"><label>26</label><element-citation publication-type="journal"><collab>American Thoracic Society</collab><article-title>Evidence-based colloid use in the critically ill: American Thoracic Society Consensus Statement</article-title><source>Am J Respir Crit Care Med</source><year>2004</year><volume>170</volume><fpage>1247</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">15563641</pub-id></element-citation></ref><ref id="CIT0027"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aujesky</surname><given-names>D</given-names></name><name><surname>Auble</surname><given-names>TE</given-names></name><name><surname>Yealy</surname><given-names>DM</given-names></name><etal/></person-group><article-title>Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia</article-title><source>Am J Med</source><year>2005</year><volume>118</volume><fpage>384</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">15808136</pub-id></element-citation></ref><ref id="CIT0028"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niederman</surname><given-names>MS</given-names></name><name><surname>Mandell</surname><given-names>LA</given-names></name><name><surname>Anzueto</surname><given-names>A</given-names></name><etal/></person-group><article-title>Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention</article-title><source>Am J Respir Crit Care Med</source><year>2001</year><volume>163</volume><fpage>1730</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">11401897</pub-id></element-citation></ref><ref id="CIT0029"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houck</surname><given-names>PM</given-names></name><name><surname>Bratzler</surname><given-names>DW</given-names></name><name><surname>Nsa</surname><given-names>W</given-names></name><name><surname>Ma</surname><given-names>A</given-names></name><name><surname>Bartlett</surname><given-names>JG</given-names></name></person-group><article-title>Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia</article-title><source>Arch Intern Med</source><year>2004</year><volume>164</volume><fpage>637</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">15037492</pub-id></element-citation></ref><ref id="CIT0030"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrer</surname><given-names>R</given-names></name><name><surname>Artigas</surname><given-names>A</given-names></name><name><surname>Suarez</surname><given-names>D</given-names></name><etal/></person-group><article-title>Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study</article-title><source>Am J Respir Crit Care Med</source><year>2009</year><volume>180</volume><fpage>861</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">19696442</pub-id></element-citation></ref><ref id="CIT0031"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaieski</surname><given-names>DF</given-names></name><name><surname>Mikkelsen</surname><given-names>ME</given-names></name><name><surname>Band</surname><given-names>RA</given-names></name><etal/></person-group><article-title>Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department</article-title><source>Crit Care Med</source><year>2010</year><volume>38</volume><fpage>1045</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">20048677</pub-id></element-citation></ref><ref id="CIT0032"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>HB</given-names></name><name><surname>Lynch</surname><given-names>EL</given-names></name><name><surname>Mou</surname><given-names>JA</given-names></name><name><surname>Lyon</surname><given-names>K</given-names></name><name><surname>Wittlake</surname><given-names>WA</given-names></name><name><surname>Corbett</surname><given-names>SW</given-names></name></person-group><article-title>The utility of a quality improvement bundle in bridging the gap between research and standard care in the management of severe sepsis and septic shock in the emergency department</article-title><source>Acad Emerg Med</source><year>2007</year><volume>14</volume><fpage>1079</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">17923718</pub-id></element-citation></ref><ref id="CIT0033"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schramm</surname><given-names>GE</given-names></name><name><surname>Kashyap</surname><given-names>R</given-names></name><name><surname>Mullon</surname><given-names>JJ</given-names></name><name><surname>Gajic</surname><given-names>O</given-names></name><name><surname>Afessa</surname><given-names>B</given-names></name></person-group><article-title>Septic shock: a multidisciplinary response team and weekly feedback to clinicians improve the process of care and mortality</article-title><source>Crit Care Med</source><year>2011</year><volume>39</volume><fpage>252</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">21057312</pub-id></element-citation></ref><ref id="CIT0034"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>MM</given-names></name><name><surname>Macias</surname><given-names>WL</given-names></name><name><surname>Vincent</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Early changes in organ function predict eventual survival in severe sepsis</article-title><source>Crit Care Med</source><year>2005</year><volume>33</volume><fpage>2194</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">16215369</pub-id></element-citation></ref><ref id="CIT0035"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cronshaw</surname><given-names>HL</given-names></name><name><surname>Daniels</surname><given-names>R</given-names></name><name><surname>Bleetman</surname><given-names>A</given-names></name><name><surname>Joynes</surname><given-names>E</given-names></name><name><surname>Sheils</surname><given-names>M</given-names></name></person-group><article-title>Impact of the surviving sepsis campaign on the recognition and management of severe sepsis in the emergency department: are we failing?</article-title><source>Emerg Med J</source><year>2011</year><volume>28</volume><fpage>670</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">20660901</pub-id></element-citation></ref><ref id="CIT0036"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castellanos-Ortega</surname><given-names>A</given-names></name><name><surname>Suberviola</surname><given-names>B</given-names></name><name><surname>Garc&#x000ed;a-Astudillo</surname><given-names>LA</given-names></name><etal/></person-group><article-title>Impact of the surviving sepsis campaign protocols on hospital length of stay and mortality in septic shock patients: results of a three-year follow-up quasi-experimental study</article-title><source>Crit Care Med</source><year>2010</year><volume>38</volume><fpage>1036</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">20154597</pub-id></element-citation></ref><ref id="CIT0037"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrer</surname><given-names>R</given-names></name><name><surname>Artigas</surname><given-names>A</given-names></name><name><surname>Levy</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain</article-title><source>JAMA</source><year>2008</year><volume>299</volume><fpage>2294</fpage><lpage>303</lpage><pub-id pub-id-type="pmid">18492971</pub-id></element-citation></ref></ref-list></back></article>